Grainger Q2 FY26 diluted EPS climbs 20.5% to $12.01; net sales rise 10.3% to $5.02 billion
Reuters2026/08/04 12:07- Grainger posted Q2 2026 net earnings attributable to shareholders of USD 570 million, up 18.3%, while diluted EPS rose 20.5% to USD 12.01.
- Net sales climbed 10.3% to USD 5.02 billion, while operating earnings increased 19% to USD 807 million.
- Operating margin widened 1.2 percentage points to 16.1%, inclusive of USD 43 million of IEEPA tariff refunds that reduced cost of goods sold.
- Full-year 2026 outlook increased, including diluted earnings per share of USD 45.50 to USD 47.25 on net sales of USD 19.4 billion to USD 19.7 billion.
- CEO D.G. Macpherson cited strong execution despite geopolitical uncertainty, pointing to momentum in the demand environment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Liquidity Unconcerned? The Federal Reserve Hits 'Pause' Again, Ceasing Reserve Management Bond Purchases Until Mid-October
The Federal Reserve announced on Monday that it will not conduct short-term Treasury bond purchases for reserve management purposes in the next phase for the second consecutive month, indicating that policymakers are satisfied with the level of bank reserves in the financial system.

Trump connects with Jensen Huang: Slams AI threat as a "scam" and strongly supports data centers, calling them the "oil of the future"
Trump participated in a live call with Jensen Huang, denouncing the AI threat narrative as a scam and stating that data centers are the oil of the future. Despite Nvidia's stock price dropping due to slowdown concerns, Jensen Huang still responded to security warnings.

AI Risks and Calls for "Slowdown" Intensify; U.S. Cybersecurity Stocks Surge Collectively
On Monday, cybersecurity stocks generally rose. As concerns grow among investors about the potential harm artificial intelligence could cause to humanity, and some industry leaders call for slowing down AI development, capital is shifting toward the cybersecurity and related enterprise software sectors.

Telix Pharma CFO Darren Charlton Smith acquires 2,071 common shares for AUD 19,999.58